Sodhi Rupinder K, Singh Manjeet, Singh Nirmal, Jaggi Amteshwar S
ASBASJS College of Pharmacy, Bela (Ropar), Punjab, India.
Arch Pharm Res. 2009 Jul;32(7):1037-43. doi: 10.1007/s12272-009-1709-9. Epub 2009 Jul 31.
The present study was designed to investigate the cardio-protective effect of Ac-LEDH-cmk a selective caspase-9 inhibitor and 5-aminoisoquinolinone a selective Poly (ADP-ribose) polymerase inhibitor on ischemia and reperfusion induced apoptotic and necrotic cell death in rats. Isolated rat hearts were exposed to 30 minutes of global ischemia followed by 120 minutes of reperfusion using Langendorff's apparatus. Myocardial injury was assessed in the terms of infarct size, release of lactate dehydrogenase, creatine kinase enzymes and apoptotic index was assessed by DNA smearing on agarose gel electrophoresis. Pretreatments with specific inhibitor of caspase-9, Ac-LEHD-cmk (0.07 muM and 0.105 muM), and inhibitor of PARP, 5-aminoisoquinolinone (5 microM and 7.5 muM), significantly attenuated I/R induced increase in infarct size, release of lactate dehydrogenase and creatine kinase in the coronary effluent, and apoptotic index. Therefore, it may be concluded that inhibition of caspase-9 and PARP prevent ischemia and reperfusion-induced activation of apoptotic cascade and necrosis in rat myocardium.
本研究旨在探讨选择性半胱天冬酶 -9抑制剂Ac-LEDH-cmk和选择性聚(ADP-核糖)聚合酶抑制剂5-氨基异喹啉酮对大鼠缺血再灌注诱导的凋亡和坏死性细胞死亡的心脏保护作用。使用Langendorff装置将离体大鼠心脏暴露于30分钟的全心缺血,随后再灌注120分钟。根据梗死面积评估心肌损伤,通过琼脂糖凝胶电泳上的DNA涂片评估乳酸脱氢酶、肌酸激酶的释放以及凋亡指数。用半胱天冬酶 -9的特异性抑制剂Ac-LEHD-cmk(0.07μM和0.105μM)和PARP抑制剂5-氨基异喹啉酮(5μM和7.5μM)预处理,可显著减轻缺血/再灌注诱导的梗死面积增加、冠状动脉流出液中乳酸脱氢酶和肌酸激酶的释放以及凋亡指数。因此,可以得出结论,抑制半胱天冬酶 -9和PARP可预防大鼠心肌缺血再灌注诱导的凋亡级联反应激活和坏死。